2Geroge JN, Woolf SH, Raskob GE, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology[J].Blood, 1996,88 ( 1 ) : 3-40.
3Portielje JE, Westendorp RG, Kluin-Nelemans HC, et al. Morbidity and mortality in adults with idiopathic thrombocytopenic purpura[J]. Blood, 2001,97 ( 9 ) : 2549-2554.
4Mazzucconi MG,Fazi P,Bernaseoni S, et al. Therapy with high- dose dexamethasone ( HD-DXM ) in previously untreated patients affected by idiopathic thromboeytopenic purpura: a GIMEMA experience[J]. Blood,2007,109(4) : 1401-1407.
5Cheng Y,Wong RS, Soo YO, et al. Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone[J]. N Engl J Med,2003,349(9):831- 836.
6Schreiber AD, Chien P, Tomaski A, et al. Effect of danazol in immune thrombocytopenic purpura[J]. N Engl J Med, 1987,316 (9) : 503-508.
